Trademark Overview
On Thursday, October 9, 2025, a trademark application was filed for ASCELIA with the United States Patent and Trademark Office. The USPTO has given the ASCELIA trademark a serial number of 79436062. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 30, 2025. This trademark is owned by Ascelia Pharma AB. The ASCELIA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; contrast media and contrast agents for use in vivo; contrast media and contrast agents for use in vitro.
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry; chemical products for scientific purposes; biochemicals for in vitro and in vivo scientific use; chemicals for use in vitro scientific use.
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; bacteriological and biological research; clinical trials; research and development of new products for others; scientific laboratory services.
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; advisory and consulting services relating to medical and diagnostic products; advisory and consulting services relating to use of contrast media and contrast agents in medical and diagnostic examinations; advisory and consulting services relating to medical and diagnostic imaging and imaging technologies; medical and diagnostic consulting services.
